{"id":"NCT00474539","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants","officialTitle":"A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With a Meningococcal C-Tetanus Toxoid Conjugate Vaccine and Other Routine Pediatric Vaccinations in Spain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2009-03","completion":"2009-03","firstPosted":"2007-05-17","resultsPosted":"2013-03-05","lastUpdate":"2013-03-05"},"enrollment":449,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Vaccines, Pneumococcal"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"7-valent pneumococcal conjugate vaccine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate (13vPnC) vaccine compared to Prevenar (7vPnC), when given concomitantly with routine paediatric vaccinations in Spain.","primaryOutcome":{"measure":"Percentage of Participants Achieving a Serum Bactericidal Assay (SBA) Titer â‰¥ 1:8 in 13vPnC Group Relative to 7vPnC Group After the 2-dose NeisVac-C Infant Series","timeFrame":"One month after infant series dose (at 5 months of age)","effectByArm":[{"arm":"13vPnC After Infant Series Dose 2","deltaMin":98.5,"sd":null},{"arm":"7vPnC After Infant Series Dose 2","deltaMin":99.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":27,"countries":["Spain"]},"refs":{"pmids":["23965217"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":218},"commonTop":["Irritability","Decreased appetite","Tenderness (any)","Increased sleep","Erythema (any)"]}}